The enzyme stabilizers for point-of-care market size has grown strongly in recent years. It will grow from $1.53 billion in 2025 to $1.68 billion in 2026 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to increasing use of point-of-care diagnostic tests, growing demand for enzyme-based rapid tests, expansion of home care testing, rising need for temperature-stable formulations, adoption of lyophilized enzyme technologies.
The enzyme stabilizers for point-of-care market size is expected to see strong growth in the next few years. It will grow to $2.41 billion in 2030 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to increasing deployment of multi-assay enzyme kits, growing demand for portable diagnostic enzyme kits, rising adoption of protein-based stabilizer solutions, expansion of field testing and clinical enzyme kits, increasing focus on shelf-life extension and cold chain independent formulations. Major trends in the forecast period include rising demand for lyophilized enzyme formulations, increasing adoption of ready-to-use liquid stabilizer solutions, growing focus on room temperature stable enzyme kits, expansion of enzyme stabilization for rapid diagnostic devices, rising preference for multi-enzyme preservation tablets.
The increasing investment in healthcare infrastructure is expected to fuel the growth of the enzyme stabilizers for point-of-care market over the forecast period. Healthcare infrastructure investment involves allocating public and private funds to construct, upgrade, and modernize healthcare facilities, diagnostic laboratories, medical equipment, and supporting systems to improve the quality, efficiency, and accessibility of healthcare services. Such investments are growing in response to aging populations, rising disease burdens, and the increasing need for advanced and decentralized diagnostic technologies. Enzyme stabilizers play a crucial role in these settings, as they maintain the activity and reliability of enzymes used in rapid diagnostic assays under varying storage and operating conditions, ensuring accurate and consistent on-site test results. For example, in May 2023, according to the UK Department of Health and Social Care, the government confirmed that the New Hospital Programme would receive over $27.02 billion (£20 billion) in funding for hospital infrastructure. Therefore, the increasing healthcare infrastructure investment is driving the growth of the enzyme stabilizers for point-of-care market.
Leading companies operating in the Enzyme Stabilizers for Point-of-Care market are focusing on developing innovative solutions such as controlled and consistent DNA fragmentation to enhance assay reliability, reduce variability, simplify workflows, and enable rapid, decentralized molecular testing at the point of care. Controlled and consistent DNA fragmentation is the precise and reproducible breaking of DNA into defined fragment sizes using enzymatic or mechanical methods, ensuring uniformity for reliable downstream applications like sequencing or diagnostics. For example, in February 2026, Meridian Bioscience, Inc., a U.S.-based life science and diagnostic raw materials company, launched its Lyophilized NGS Enzymatic DNA Fragmentation Kit, an ambient-temperature stable enzymatic reagent system designed to simplify next-generation sequencing workflows for point-of-care and decentralized testing by eliminating cold-chain storage, enabling precise time-controlled DNA fragmentation with consistent activity after long-term ambient storage, reducing handling complexities, and supporting a wide range of sequencing applications where stability and ease of use are critical.
In January 2025, Medix Biochemica, a Finland-based healthcare technology company, acquired CANDOR Bioscience GmbH for an undisclosed sum. With this acquisition, Medix Biochemica aimed to strategically enhance and diversify its portfolio of critical raw materials for the in vitro diagnostics (IVD) industry and improve its support and technological capabilities for immunoassay developers globally. CANDOR Bioscience GmbH is a Germany-based biotechnology company specializing in various enzyme stabilizers used in the development and production of point-of-care (POC) and in vitro diagnostic (IVD) tests.
Major companies operating in the enzyme stabilizers for point-of-care market are market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Siemens Healthineers AG, Merck KGaA, Becton Dickinson Company, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Novonesis Inc., QIAGEN N.V., Amano Enzyme Inc., Surmodics Inc., Arista Biologicals Inc., BBI Solutions Ltd., Sisco Research Laboratories Pvt. Ltd., Advanced Enzyme Technologies Ltd., Codexis Inc., Enzo Life Sciences Inc., Biocatalysts Ltd., Enzyme Solutions Inc., Creative Enzymes Inc.
North America was the largest region in the enzyme stabilizers for point-of-care market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the enzyme stabilizers for point-of-care market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the enzyme stabilizers for point-of-care market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The enzyme stabilizers for point-of-care market consists of sales of enzyme preservation tablets, and pre-formulated enzyme kits, composite enzyme protectants, and protein-free stabilizers. Values in this market are “factory gate” values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services such as technical support, formulation customization, regulatory compliance assistance, and storage and handling guidance sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Enzyme stabilizers for point-of-care are chemical formulations designed to maintain the stability and activity of enzymes used in rapid diagnostic tests near patient care settings. They protect enzymes from degradation caused by temperature fluctuations, moisture, and other environmental factors. These stabilizers ensure reliable performance and consistent diagnostic results outside standard laboratory conditions.
The key product types of enzyme stabilizers for point-of-care include lyophilized enzyme formulations, liquid enzyme stabilizer solutions, enzyme preservation tablets, pre-formulated enzyme kits, and other variants. Lyophilized enzyme formulations are dried enzyme preparations designed to enhance stability and extend shelf life under varying storage conditions. Formulations include liquid, lyophilized, and others, distributed through direct sales, distributors, online sales, and other channels. Applications include diagnostic devices, biosensors, rapid test kits, and others, serving diagnostic kit manufacturers, hospitals and clinics, homecare settings, research laboratories, and other end users.
Tariffs on imported chemical stabilizers, enzyme raw materials, and diagnostic kit components are impacting the enzyme stabilizers for point-of-care market by raising costs for manufacturers, especially affecting lyophilized and liquid stabilizer solutions. Regions such as North America, Europe, and Asia-Pacific that rely on imported enzymes and chemical formulations are most affected. While tariffs increase production costs, they also encourage local production, boost domestic enzyme stabilization innovation, and promote development of cost-effective, room-temperature stable formulations, creating opportunities for regional suppliers.
The enzyme stabilizers for point-of-care market research report is one of a series of new reports that provides enzyme stabilizers for point-of-care market statistics, including enzyme stabilizers for point-of-care industry global market size, regional shares, competitors with a enzyme stabilizers for point-of-care market share, detailed enzyme stabilizers for point-of-care market segments, market trends and opportunities, and any further data you may need to thrive in the enzyme stabilizers for point-of-care industry. This enzyme stabilizers for point-of-care market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
This product will be delivered within 1-3 business days.
The enzyme stabilizers for point-of-care market size is expected to see strong growth in the next few years. It will grow to $2.41 billion in 2030 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to increasing deployment of multi-assay enzyme kits, growing demand for portable diagnostic enzyme kits, rising adoption of protein-based stabilizer solutions, expansion of field testing and clinical enzyme kits, increasing focus on shelf-life extension and cold chain independent formulations. Major trends in the forecast period include rising demand for lyophilized enzyme formulations, increasing adoption of ready-to-use liquid stabilizer solutions, growing focus on room temperature stable enzyme kits, expansion of enzyme stabilization for rapid diagnostic devices, rising preference for multi-enzyme preservation tablets.
The increasing investment in healthcare infrastructure is expected to fuel the growth of the enzyme stabilizers for point-of-care market over the forecast period. Healthcare infrastructure investment involves allocating public and private funds to construct, upgrade, and modernize healthcare facilities, diagnostic laboratories, medical equipment, and supporting systems to improve the quality, efficiency, and accessibility of healthcare services. Such investments are growing in response to aging populations, rising disease burdens, and the increasing need for advanced and decentralized diagnostic technologies. Enzyme stabilizers play a crucial role in these settings, as they maintain the activity and reliability of enzymes used in rapid diagnostic assays under varying storage and operating conditions, ensuring accurate and consistent on-site test results. For example, in May 2023, according to the UK Department of Health and Social Care, the government confirmed that the New Hospital Programme would receive over $27.02 billion (£20 billion) in funding for hospital infrastructure. Therefore, the increasing healthcare infrastructure investment is driving the growth of the enzyme stabilizers for point-of-care market.
Leading companies operating in the Enzyme Stabilizers for Point-of-Care market are focusing on developing innovative solutions such as controlled and consistent DNA fragmentation to enhance assay reliability, reduce variability, simplify workflows, and enable rapid, decentralized molecular testing at the point of care. Controlled and consistent DNA fragmentation is the precise and reproducible breaking of DNA into defined fragment sizes using enzymatic or mechanical methods, ensuring uniformity for reliable downstream applications like sequencing or diagnostics. For example, in February 2026, Meridian Bioscience, Inc., a U.S.-based life science and diagnostic raw materials company, launched its Lyophilized NGS Enzymatic DNA Fragmentation Kit, an ambient-temperature stable enzymatic reagent system designed to simplify next-generation sequencing workflows for point-of-care and decentralized testing by eliminating cold-chain storage, enabling precise time-controlled DNA fragmentation with consistent activity after long-term ambient storage, reducing handling complexities, and supporting a wide range of sequencing applications where stability and ease of use are critical.
In January 2025, Medix Biochemica, a Finland-based healthcare technology company, acquired CANDOR Bioscience GmbH for an undisclosed sum. With this acquisition, Medix Biochemica aimed to strategically enhance and diversify its portfolio of critical raw materials for the in vitro diagnostics (IVD) industry and improve its support and technological capabilities for immunoassay developers globally. CANDOR Bioscience GmbH is a Germany-based biotechnology company specializing in various enzyme stabilizers used in the development and production of point-of-care (POC) and in vitro diagnostic (IVD) tests.
Major companies operating in the enzyme stabilizers for point-of-care market are market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Siemens Healthineers AG, Merck KGaA, Becton Dickinson Company, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Novonesis Inc., QIAGEN N.V., Amano Enzyme Inc., Surmodics Inc., Arista Biologicals Inc., BBI Solutions Ltd., Sisco Research Laboratories Pvt. Ltd., Advanced Enzyme Technologies Ltd., Codexis Inc., Enzo Life Sciences Inc., Biocatalysts Ltd., Enzyme Solutions Inc., Creative Enzymes Inc.
North America was the largest region in the enzyme stabilizers for point-of-care market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the enzyme stabilizers for point-of-care market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the enzyme stabilizers for point-of-care market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The enzyme stabilizers for point-of-care market consists of sales of enzyme preservation tablets, and pre-formulated enzyme kits, composite enzyme protectants, and protein-free stabilizers. Values in this market are “factory gate” values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services such as technical support, formulation customization, regulatory compliance assistance, and storage and handling guidance sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Enzyme stabilizers for point-of-care are chemical formulations designed to maintain the stability and activity of enzymes used in rapid diagnostic tests near patient care settings. They protect enzymes from degradation caused by temperature fluctuations, moisture, and other environmental factors. These stabilizers ensure reliable performance and consistent diagnostic results outside standard laboratory conditions.
The key product types of enzyme stabilizers for point-of-care include lyophilized enzyme formulations, liquid enzyme stabilizer solutions, enzyme preservation tablets, pre-formulated enzyme kits, and other variants. Lyophilized enzyme formulations are dried enzyme preparations designed to enhance stability and extend shelf life under varying storage conditions. Formulations include liquid, lyophilized, and others, distributed through direct sales, distributors, online sales, and other channels. Applications include diagnostic devices, biosensors, rapid test kits, and others, serving diagnostic kit manufacturers, hospitals and clinics, homecare settings, research laboratories, and other end users.
Tariffs on imported chemical stabilizers, enzyme raw materials, and diagnostic kit components are impacting the enzyme stabilizers for point-of-care market by raising costs for manufacturers, especially affecting lyophilized and liquid stabilizer solutions. Regions such as North America, Europe, and Asia-Pacific that rely on imported enzymes and chemical formulations are most affected. While tariffs increase production costs, they also encourage local production, boost domestic enzyme stabilization innovation, and promote development of cost-effective, room-temperature stable formulations, creating opportunities for regional suppliers.
The enzyme stabilizers for point-of-care market research report is one of a series of new reports that provides enzyme stabilizers for point-of-care market statistics, including enzyme stabilizers for point-of-care industry global market size, regional shares, competitors with a enzyme stabilizers for point-of-care market share, detailed enzyme stabilizers for point-of-care market segments, market trends and opportunities, and any further data you may need to thrive in the enzyme stabilizers for point-of-care industry. This enzyme stabilizers for point-of-care market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Enzyme Stabilizers for Point-of-Care Market Characteristics
3. Enzyme Stabilizers for Point-of-Care Market Supply Chain Analysis
4. Global Enzyme Stabilizers for Point-of-Care Market Trends and Strategies
5. Enzyme Stabilizers for Point-of-Care Market Analysis of End Use Industries
7. Global Enzyme Stabilizers for Point-of-Care Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Enzyme Stabilizers for Point-of-Care Total Addressable Market (TAM) Analysis for the Market
9. Enzyme Stabilizers for Point-of-Care Market Segmentation
10. Enzyme Stabilizers for Point-of-Care Market Regional and Country Analysis
11. Asia-Pacific Enzyme Stabilizers for Point-of-Care Market
12. China Enzyme Stabilizers for Point-of-Care Market
13. India Enzyme Stabilizers for Point-of-Care Market
14. Japan Enzyme Stabilizers for Point-of-Care Market
15. Australia Enzyme Stabilizers for Point-of-Care Market
16. Indonesia Enzyme Stabilizers for Point-of-Care Market
17. South Korea Enzyme Stabilizers for Point-of-Care Market
18. Taiwan Enzyme Stabilizers for Point-of-Care Market
19. South East Asia Enzyme Stabilizers for Point-of-Care Market
20. Western Europe Enzyme Stabilizers for Point-of-Care Market
21. UK Enzyme Stabilizers for Point-of-Care Market
22. Germany Enzyme Stabilizers for Point-of-Care Market
23. France Enzyme Stabilizers for Point-of-Care Market
24. Italy Enzyme Stabilizers for Point-of-Care Market
25. Spain Enzyme Stabilizers for Point-of-Care Market
26. Eastern Europe Enzyme Stabilizers for Point-of-Care Market
27. Russia Enzyme Stabilizers for Point-of-Care Market
28. North America Enzyme Stabilizers for Point-of-Care Market
29. USA Enzyme Stabilizers for Point-of-Care Market
30. Canada Enzyme Stabilizers for Point-of-Care Market
31. South America Enzyme Stabilizers for Point-of-Care Market
32. Brazil Enzyme Stabilizers for Point-of-Care Market
33. Middle East Enzyme Stabilizers for Point-of-Care Market
34. Africa Enzyme Stabilizers for Point-of-Care Market
36. Enzyme Stabilizers for Point-of-Care Market Competitive Landscape and Company Profiles
37. Enzyme Stabilizers for Point-of-Care Market Other Major and Innovative Companies
41. Enzyme Stabilizers for Point-of-Care Market High Potential Countries, Segments and Strategies
42. Appendix
Executive Summary
Enzyme Stabilizers For Point-Of-Care Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses enzyme stabilizers for point-of-care market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for enzyme stabilizers for point-of-care? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The enzyme stabilizers for point-of-care market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Lyophilized Enzyme Formulations; Liquid Enzyme Stabilizer Solutions; Enzyme Preservation Tablets; Pre-Formulated Enzyme Kits; Other Product Types2) By Formulation: Liquid; Lyophilized; Other Formulations
3) By Distribution Channel: Direct Sales; Distributors; Online Sales; Other Distributional Channels
4) By Application: Diagnostic Devices; Biosensors; Rapid Test Kits; Other Applications
5) By End User: Diagnostic Kit Manufacturers; Hospitals and Clinics; Home Care Settings; Research Laboratories; Other End Users
Subsegments:
1) By Lyophilized Enzyme Formulations: Freeze Dried Single Enzyme Preparations; Freeze Dried Multi Enzyme Preparations; Long Shelf Life Formulations; Room Temperature Stable Formulations; Cold Chain Stable Formulations2) By Liquid Enzyme Stabilizer Solutions: Aqueous Stabilizer Solutions; Buffered Stabilizer Solutions; Glycerol Based Stabilizer Solutions; Protein Based Stabilizer Solutions; Ready To Use Stabilizer Solutions
3) By Enzyme Preservation Tablets: Rapid Dissolution Tablets; Controlled Release Tablets; Room Temperature Stable Tablets; Blister Packed Tablets; Multi Enzyme Preservation Tablets
4) By Pre-Formulated Enzyme Kits: Single Assay Enzyme Kits; Multi Assay Enzyme Kits; Portable Diagnostic Enzyme Kits; Field Testing Enzyme Kits; Clinical Testing Enzyme Kits
5) By Other Product Types: Enzyme Stabilizing Beads; Enzyme Stabilizing Films; Coated Enzyme Strips; Encapsulated Enzyme Particles; Immobilized Enzyme Matrices
Companies Mentioned: F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Siemens Healthineers AG; Merck KGaA; Becton Dickinson Company; Agilent Technologies Inc.; Bio-Rad Laboratories Inc.; Novonesis Inc.; QIAGEN N.V.; Amano Enzyme Inc.; Surmodics Inc.; Arista Biologicals Inc.; BBI Solutions Ltd.; Sisco Research Laboratories Pvt. Ltd.; Advanced Enzyme Technologies Ltd.; Codexis Inc.; Enzo Life Sciences Inc.; Biocatalysts Ltd.; Enzyme Solutions Inc.; Creative Enzymes Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Enzyme Stabilizers for Point-of-Care market report include:- F. Hoffmann-La Roche AG
- Thermo Fisher Scientific Inc.
- Siemens Healthineers AG
- Merck KGaA
- Becton Dickinson Company
- Agilent Technologies Inc.
- Bio-Rad Laboratories Inc.
- Novonesis Inc.
- QIAGEN N.V.
- Amano Enzyme Inc.
- Surmodics Inc.
- Arista Biologicals Inc.
- BBI Solutions Ltd.
- Sisco Research Laboratories Pvt. Ltd.
- Advanced Enzyme Technologies Ltd.
- Codexis Inc.
- Enzo Life Sciences Inc.
- Biocatalysts Ltd.
- Enzyme Solutions Inc.
- Creative Enzymes Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | May 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.68 Billion |
| Forecasted Market Value ( USD | $ 2.41 Billion |
| Compound Annual Growth Rate | 9.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
